New research letter compares melanoma death and incidence by states and geographic regions

A new research letter published online by JAMA Dermatology compares melanoma death and incidence by states and in four geographic regions.

Melanoma death and incidence rates vary among states, partly because of demographic differences.

Robert P. Dellavalle, M.D., Ph.D., M.S.P.H., of the Denver Veterans Affairs Medical Center and the University of Colorado School of Medicine, Aurora, and coauthors used a publicly available database to analyze melanoma death and incidence rates by state and geographic region. Researchers report:

  • * 23 of 48 states (with data for 2003 and 2013) had a decrease in melanoma death rates; four states had no change and 21 states saw an increase.

* 11 of the 49 states with reported melanoma incidence rates saw a decrease and 38 states had an increase.

"Promoting greater awareness of skin cancer through public health programs has been associated with increased documentation and incidence rates. Lower death rates may further indicate that better treatment may be prolonging the life of patients with melanoma. Further research into the prevalence of melanoma in these four geographic regions is needed," the article concludes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy